Ambulatory surgery centre and outpatient procedure-device buyers
Same surgical, endoscopy and interventional device families bought by freestanding ambulatory surgery centres, outpatient endoscopy suites and office-based labs rather than by hosp
Intelligence / Healthtech & medtech market map / Medical devices / Surgical and interventional devices
Devices used in operating rooms, catheterisation laboratories, endoscopy, interventional radiology and minimally invasive procedures. Includes robotic, electrophysiology, structural heart, orthopaedic and general surgical devices and their consumables.
Split by customer type.
Same surgical, endoscopy and interventional device families bought by freestanding ambulatory surgery centres, outpatient endoscopy suites and office-based labs rather than by hosp
Recurring, procedure-attached consumables used in surgical, endoscopic, interventional radiology and electrophysiology procedures: guidewires, catheters, stents, staplers, sutures,
Devices and consumables bought by hospital OR/cath-lab/endoscopy departments for open and minimally invasive procedures: surgical instruments, energy devices, staplers, sutures, im
Devices sold for catheter-based and transcatheter treatment of cardiovascular disease: diagnostic and interventional catheters, guidewires, balloon and stent systems, transcatheter
Devices and consumables purchased by independent physician practices, physician-owned ASCs and office-based labs for in-office and outpatient procedures, including endoscopy, minor
Named in public sources; linked to the source.
$193B ($180B–$198B) · 2026 · Top-down
Source [6] assigns 31% of global medical-device revenue to surgical, endoscopy and robotic systems. Arithmetic: $623.37bn x 31% = $193.245bn in 2026. The low and high estimates apply the same share to the $580bn and $640bn sector ranges from [4]. Forecast assumes the share remains constant: $193.245bn x 1.0634^9 = $336.030bn in 2035.
// Sell into Surgical and interventional devices